USPTO trademark

SELECT

RegisteredUSPTOFigurative markClass 9Class 16Class 42Class 44

"SELECT" is a figurative mark owned by Olympus Corporation, filed at the USPTO on August 16, 2022. It is registered and covers classes 9, 16, 42 and 44.

Official USPTO record
SELECT trademark as filed
As filed with the USPTO
Status
Registered
Since May 12, 2026
Filed
August 16, 2022
Registered
May 12, 2026
Expires
Not recorded
Application no.
97551508
Registration no.
8254047
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
4 classes
Ownership

Who owns SELECT

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services SELECT is filed for, grouped by Nice class.

  • Downloadable reports and documents in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in connection with the visual readings of lung structures; downloadable reports and documents featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; downloadable reports and documents featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease

  • Printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical and medical information in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring surgical information, medical information, and quantitative measures for use in connection with the evaluation, surgical treatment, and medical treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine and quantitative computed tomography analysis; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures to support visual readings of lung structures; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing in the field of pulmonary medicine featuring surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; printed materials, namely, printed reports and printed medical records comprising analyses of results of medical diagnostic testing featuring information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions and emphysema disease

  • Providing temporary use of online non-downloadable software for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of online non-downloadable software featuring artificial intelligence for quantitative computed tomography analysis in the field of pulmonary medicine and pulmonary disease, and generating reports corresponding to the foregoing; providing temporary use of on-line non-downloadable software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease and generating reports corresponding to the foregoing; software as a service (SAAS) services featuring software for analyzing patient data in the field of pulmonary medicine and the evaluation and treatment of chronic obstructive pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease, and generating reports corresponding to the foregoing; software as a services (SAAS) services featuring software for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring software using artificial intelligence for quantitative data analysis of computed tomography scans and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing and submitting medical information in the form of computed tomography scans, receiving quantitative data analysis of computed tomography scans, and generating corresponding reports, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures to support visual readings of lung structures, all in the field of pulmonary medicine; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing surgical information, medical information, and quantitative measures for use in confirming the eligibility of patients and the identification of correct target lobes for endobronchial valve treatment; software as a services (SAAS) services featuring temporary use of non-downloadable software for use in securely accessing information about medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease

  • Providing medical information regarding medical devices for the treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease; medical diagnostic testing, monitoring and reporting services in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; medical information services, namely, analysis and reporting services relating to the treatment of patients based on quantitative measurements of computed tomography scans in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing online medical record analysis services designed to provide patients and practitioners with customized data used to inform and recommend treatment options in the field of pulmonary medicine, pulmonary disease and pulmonary conditions; providing a website featuring online medical information regarding medical devices and medical procedures for use in connection with the evaluation and treatment of pulmonary disease, chronic obstructive pulmonary disease, pulmonary disease and pulmonary conditions, and emphysema disease

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Notice of approval of extension request e-mailed
  10. Sou extension 2 granted

10 earlier steps on the official record.

Disputes

Oppositions and cancellations

Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.

FAQ

About SELECT

Who owns the trademark "SELECT"?

The USPTO trademark "SELECT" (application 97551508) is owned by Olympus Corporation.

What is the status of "SELECT"?

Its status at the USPTO is: registered.

When was "SELECT" registered?

It was registered on May 12, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SELECT and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2adc-508b-76ee-9975-5fdc1642eefb
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2adc-508b-76ee-9975-5fdc1642eefb",
  "object": "trademark",
  "mark_text": "SELECT",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97551508",
  "filing_date": "2022-08-16",
  "nice_classes": [
    9,
    16,
    42,
    44
  ],
  "owners": [
    {
      "name": "Olympus Corporation",
      "entity_id": "ent_019eb6f6-bb3a-766e-b601-9bd844892694"
    }
  ]
}